Collaborations & Alliances, Trials & Filings

Menarini Launches PE Drug in UK

Triggers milestone payment to Furiex

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

The Menarini Group has launched Priligy, an on-demand treatment of premature ejaculation, in the UK. Priligy is marketed for that indication in more than 20 countries in Europe, Asia and Latin America, and is approved for that indication in more than 60 countries worldwide. The UK launch triggered a $5.0 million milestone payment from Menarini to Furiex Pharmaceuticals, Inc. (FURX), a drug development collaboration company. In May 2012, Furiex entered into a license agreement with Menarini to c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters